CDH1 and neoplasm: Though some studies have explored the immunoreactivity of E - cadherin in potentially malignant disorders, non-tumor epithelium adjacent to oral cancer and oral squamous cell carcinoma, it remains unclear if E - cadherin could be used as a bio-marker to predict malignant transformation.